CJC-1295 (No DAC)

CJC-1295 (DAC & Non-DAC)

Research-Grade GHRH Analogue
Tagline: Growth Hormone Research Tool

Product Description

CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analogue designed to increase growth hormone (GH) secretion by binding to GHRH receptors in the pituitary. It is available in two forms: CJC-1295 with DAC (Drug Affinity Complex) for prolonged half-life and CJC-1295 without DAC for shorter, more pulsatile GH release.

Researchers use CJC-1295 peptide to study GH/IGF-1 axis regulation, metabolism, and recovery pathways in preclinical models. Its ability to induce sustained GH release makes it an important tool in endocrine and metabolic research.

For Laboratory and Scientific Research Use Only. Not for Human Consumption.

Why Researchers Choose CJC-1295 Peptide

• High Purity: ≥98% purity ensures reproducible experimental results.

• Extended Half-Life: DAC version allows weekly dosing models.

• Receptor Specificity: Targets GHRH receptors with precision.

• Stability: Lyophilized form maintains potency during storage.

• Versatile Options: Available with and without DAC for different study designs.

• Batch Tested: Identity and purity verified for every lot.

Important Note

For laboratory and scientific research only. Not for human consumption, veterinary use, or diagnostic purposes.